April 24, 2014 — SCL Health System, a faith-based, nonprofit healthcare organization, announced an agreement to implement Stanson Health's next-generation clinical decision support (CDS) system. Stanson's CDS solutions are designed to safely reduce the cost and potential for harm from unnecessary care, by providing easy-to-use, real-time alerts and analytics to help guide physicians' decisions.

The global biopsy devices market value will increase at a modest rate over the coming years, climbing from $506.4 million in 2013 to $602.4 million by 2019, at a compound annual growth rate (CAGR) of 2.93%, forecasts research and consulting firm GlobalData.

The Animal Health Trust (AHT) required a non-carbon fiber, flat positioning board for its GE Healthcare CT Brivo 385 system to enable it to perform radiotherapy planning for dogs and cats from computed tomography (CT) scans.

April 23, 2014 — Researchers in Zurich, Switzerland, have successfully used focused ultrasound for the first time to noninvasively ablate part of a recurrent glioma tumor through a patient’s intact skull. The procedure was performed to assess the feasibility and safety of focused ultrasound in treating brain tumors; it was not intended to demonstrate efficacy. The procedure was conducted using InSightec's Exablate Neuro system.

April 23, 2014 — Vital Images, a Toshiba Medical Systems Group company, is experiencing a significant increased demand for its VitreaView universal viewer as healthcare leaders seek opportunities to meet Stage 2 Meaningful Use requirements, connect physicians and patients to images and integrate imaging into their EMRs (electronic medical records), HIEs (health information exchanges) and EHRs (electronic health records).

April 21, 2014 — Cardiologists and cancer experts at the Mount Sinai Hospital in Manhattan have joined forces to establish its first cardio-oncology clinic at the Tisch Cancer Institute.

Proton Therapy Center Czech is located in the capital of the Czech Republic and has successfully entered its second year of operation. Since the beginning, it has made itself available to patients from all over the world has to date has treated patients from 18 different countries — including Great Britain, France, Belgium, Germany, Norway, Switzerland and the Russian federation.